Cove Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$991K Sell
12,674
-2,198
-15% -$177K 0.19% 90
2026
Q1
$1.29M Buy
14,872
+43
+0.3% +$4.12K 0.29% 66
2025
Q4
$1.42M Sell
14,829
-1,350
-8% -$131K 0.42% 57
2025
Q3
$1.54M Sell
16,179
-450
-3% -$41.4K 0.49% 49
2025
Q2
$1.45M Buy
16,629
+1,650
+11% +$140K 0.51% 49
2025
Q1
$1.35M Buy
14,979
+84
+0.6% +$7.52K 0.71% 36
2024
Q4
$1.19M Buy
14,895
+10
+0.1% +$866 0.71% 38
2024
Q3
$1.34M Hold
14,885
1.04% 28
2024
Q2
$1.17M Hold
14,885
0.94% 32
2024
Q1
$1.3M Hold
14,885
1.11% 28
2023
Q4
$1.23M Buy
+14,885
New +$1.13M 1.16% 29

Other funds holding MDT

Cove Private Wealth's MDT Position: Q2 2026 in Review

Cove Private Wealth reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $177K and leaving 12,674 shares worth $991K. The position accounts for 0.19% of the portfolio, ranked #90.

Cove Private Wealth first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.54M in Q3 2025. 908 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cove Private Wealth held 12,674 shares of Medtronic worth $991K as of Q2 2026.
  • Cove Private Wealth sold 2,198 Medtronic shares in Q2 2026, an estimated $177K.
  • Medtronic made up 0.19% of Cove Private Wealth's portfolio in Q2 2026, its #90 holding.
  • Cove Private Wealth first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Cove Private Wealth's Medtronic position peaked at $1.54M in Q3 2025.
  • 908 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.